E-Newsletter - December 2023
Alliance Awards
 

2023 Richard L. Schilsky Cancer and Leukemia Group B Achievement Award

Jeffrey Crawford, MD
George Barth Geller Professor for Research in Cancer
Duke University Medical Center
Lead PI, NCTN LAPS Grant, Duke Cancer Institute

Lecture: “CALGB/Alliance/NCTN/NCORP:
Home Base for Cancer Research"

The RLS CALGB Achievement Award acknowledges the significant contributions of an individual to cooperative group research. It was established in 2010 to recognize the 15-year tenure of Dr. Schilsky as Group Chair of Cancer and Leukemia Group B (CALGB). This year's award recipient is Jeffrey Crawford, MD, an expert in respiratory cancers. Dr. Crawford is the George Barth Geller Professor for Research in Cancer and Clinical Director of the Medical Thoracic Oncology Program in the Duke Cancer Institute and serves as the Principal Investigator of the Duke Cancer Institute LAPS. Dr. Crawford's research interests include new treatment approaches to lung cancer (small-cell and non-small cell), chemotherapy, and hematopoietic growth factors. His research has led to U.S. Food and Drug Administration approval of trials, including one of filgrastim to reduce the morbidity of chemotherapy-related neutropenia and another of vinorelbine in the treatment of patients with advanced non-small cell lung cancer. He has published more than 250 manuscripts, chapters, and reviews. In addition, Dr. Crawford serves on the Alliance Board of Directors and is a member of the Alliance Respiratory Committee and Alliance Cancer in the Older Adult Committee.

Photos taken at 2023 Alliance Fall Hybrid Group Meeting
- Jeffrey Crawford, MD; Alliance Group Chair Evanthia Galanis, MD; and Richard L. Schilsky, MD.
- Jeffrey Crawford, MD; Alliance Group Chair Evanthia Galanis, MD; and Mrs. Crawford.

 

 

Read other articles in this month's e-newsletter:

• Message From the Group Chair
• New Alliance Leadership Appointments
• 2023 Richard L. Schilsky CALGB Achievement Award
• Recently Activated Alliance Trials
• Ongoing Alliance Trials Now Enrolling Participants
• 2022-2023 Most Notable Alliance Publications
• Spotlight on Scientific Annual Meetings: 2023 SABCS & ASH
• In Memoriam: Worta J. McCaskill-Stevens, MD, MS - Founding Director, NCI Community Oncology Research Program (NCORP)
• Alliance Foundation Special Allocation Funding Opportunity
• Alliance/Alliance Entities Holiday Closures
• Alliance in the News
  :: Patients with HR-positive Breast Cancer May Use Fertility Preservation and Assisted Reproductive Technologies Without Increased Risk of Recurrence
  :: Can Irinotecan Boost Complete Response Rate and Long-term Organ Preservation in Rectal Cancer Patients?
  :: Sex-Associated Differences in Frequencies and Prognostic Impact of Recurrent Genetic Alterations in Adult Acute Myeloid Leukemia (Alliance, AMLCG)
  :: DNA Mutational Profiling in Patients With Colorectal Cancer Treated With Standard of Care Reveals Differences in Outcome and Racial Distribution of Mutations
  :: ctDNA May Guide Treatment Intensity in RCC
  :: Quality of Life, Access Top Priorities in Cancer Care
  :: Dual-action Drug Produces Shows Promising Results In Neuroendocrine Tumor Trial
  :: Alliance for Clinical Trials in Oncology Study Shows Promise for Patients with Muscle-Invasive Urothelial Carcinoma
  :: Clinical Trial Shows Promising Results for Patients with Advanced Neuroendocrine Tumors
  :: Older, Hispanic Patients More Likely to Withdraw From Cancer Trials